Brain glucose sensing and neural regulation of insulin and glucagon secretion

Diabetes, Obesity and Metabolism

Volumn 13, Issue SUPPL. 1, 2011, Pages 82-88

  Thorens, B ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Autonomic nervous system; Brainstem; Counterregulation; Glucagon; Glucose; Glucose sensing; Hypoglycemia; Hypothalamus; Insulin; cells; cells

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM); GLUCAGON; GLUCOKINASE; GLUCOSE TRANSPORTER 2; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN;

ADIPOSE TISSUE; AUTONOMIC NERVOUS SYSTEM; BRAIN STEM; ENERGY METABOLISM; GLUCAGON RELEASE; GLUCOSE HOMEOSTASIS; GLYCEMIC CONTROL; HOMEOSTASIS; HUMAN; HYPOGLYCEMIA; HYPOTHALAMUS; INSULIN RELEASE; LIVER; METABOLIC REGULATION; MUSCLE; NERVE CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUTRIENT; PANCREAS ISLET BETA CELL; PARASYMPATHETIC FUNCTION; REVIEW;

EID: 79961206371     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2011.01453.x     Document Type: Review

References (91)

1. Carabaza A, Ciudad CJ, Baque S, Guinovart JJ. Glucose has to be phosphorylated to activate glycogen synthase, but not to inactivate glycogen phosphorylase in hepatocytes. FEBS Lett 1992; 296: 211-214.
2. Stoeckman AK, Ma L, Towle HC. Mlx is the functional heteromeric partner of the carbohydrate response element-binding protein in glucose regulation of lipogenic enzyme genes. J Biol Chem 2004; 279: 15662-15669.
3. Ma L, Tsatsos NG, Towle HC. Direct role of ChREBP.Mlx in regulating hepatic glucose-responsive genes. J Biol Chem 2005; 280: 12019-12027.
4. Wellen KE, Hatzivassiliou G, Sachdeva UM, Bui TV, Cross JR, Thompson CB. ATP-citrate lyase links cellular metabolism to histone acetylation. Science 2009; 324: 1076-1080.
5. Diez-Sampedro A, Hirayama BA, Osswald C et al. A glucose sensor hiding in a family of transporters. Proc Natl Acad Sci U S A 2003; 100: 11753-11758.
6. Treesukosol Y, Smith KR, Spector AC. The functional role of the T1R family of receptors in sweet taste and feeding. Physiol Behav. In press.
7. Wellendorph P, Johansen LD, Brauner-Osborne H. Molecular pharmacology of promiscuous seven transmembrane receptors sensing organic nutrients. Mol Pharmacol 2009; 76: 453-465.
8. Ahren B. Autonomic regulation of islet hormone secretion-implications for health and disease. Diabetologia 2000; 43: 393-410.
9. Thorens B. Central control of glucose homeostasis: the brain-endocrine pancreas axis. Diabetes Metab 2010; 36(Suppl 3): S45-S49.
10. Kaneto A, Kajinuma H, Kosaka K. Effect of splanchnic nerve stimulation on glucagon and insulin output in the dog. Endocrinology 1975; 96: 143-150.
11. Berthoud HR, Bereiter DA, Jeanrenaud B. Role of the autonomic nervous system in the mediation of LHA electrical stimulation-induced effects on insulinemia and glycemia. J Auton Nerv Syst 1980; 2: 183-198.
12. Lundquist I. Cholinergic muscarinic effects on insulin release in mice. Pharmacology 1982; 25: 338-347.
13. N'Guyen JM, Magnan C, Laury MC et al. Involvement of the autonomic nervous system in the in vivo memory to glucose of pancreatic beta cell in rats. J Clin Invest 1994; 94: 1456-1462.
14. Kiba T. Relationships between the autonomic nervous system and the pancreas including regulation of regeneration and apoptosis: recent developments. Pancreas 2004; 29: e51-58.
15. Kiba T, Tanaka K, Numata K, Hoshino M, Misugi K, Inoue S. Ventromedial hypothalamic lesion-induced vagal hyperactivity stimulates rat pancreatic cell proliferation. Gastroenterology 1996; 110: 885-893.
16. Gautam D, de Azua IR, Li JH et al. Beneficial metabolic effects caused by persistent activation of {beta}-cell M3 muscarinic acetylcholine receptors in transgenic mice. Endocrinology 2010; 151: 5185-5194.
17. Gautam D, Han SJ, Hamdan FF et al. A critical role for beta cell M3 muscarinic acetylcholine receptors in regulating insulin release and blood glucose homeostasis in vivo. Cell Metab 2006; 3: 449-461.
18. Henquin JC, Nenquin M. The muscarinic receptor subtype in mouse pancreatic B-cells. FEBS Lett 1988; 236: 89-92.
19. Berthoud HR, Trimble ER, Siegel EG, Bereiter DA, Jeanrenaud B. Cephalic-phase insulin secretion in normal and pancreatic islet-transplanted rats. Am J Physiol 1980; 238: E336-E340.
20. Berthoud HR, Bereiter DA, Trimble ER, Siegel EG, Jeanrenaud B. Cephalic phase, reflex insulin secretion. Neuroanatomical and physiological characterization. Diabetologia 1981; 20(Suppl): 393-401.
21. Berthoud HR, Jeanrenaud B. Sham feeding-induced cephalic phase insulin release in the rat. Am J Physiol 1982; 242: E280-E285.
22. Berthoud HR, Powley TL. Identification of vagal preganglionics that mediate cephalic phase insulin response. Am J Physiol 1990; 258: R523-R530.
23. Thorens B. GLUT2 in pancreatic and extra-pancreatic gluco-detection (review). Mol Membr Biol 2001; 18: 265-273.
24. Niijima A. Glucose-sensitive afferent nerve fibres in the hepatic branch of the vagus nerve in the guinea-pig. J Physiol 1982; 332: 315-323.
25. Niijima A. The effect of d-glucose on the firing rate of glucose-sensitive vagal afferents in the liver in comparison with the effect of 2-deoxy-d-glucose. J Autonom Nerv Sys 1984; 10: 279-285.
26. Balkan B, Li X. Portal GLP-1 administration in rats augments the insulin response to glucose via neuronal mechanisms. Am J Physiol 2000; 279: R1449-R1454.
27. Preitner F, Ibberson M, Franklin I et al. Gluco-incretins control insulin secretion at multiple levels as revealed in mice lacking GLP-1 and GIP receptors. J Clin Invest 2004; 113: 635-645.
28. Guillod-Maximin E, Lorsignol A, Alquier T, Penicaud L. Acute intracarotid glucose injection towards the brain induces specific c-fos activation in hypothalamic nuclei: involvement of astrocytes in cerebral glucose-sensing in rats. J Neuroendocrinol 2004; 16: 464-471.
29. Sainsbury A, Rohner-Jeanrenaud F, Cusin I et al. Chronic central neuropeptide Y infusion in normal rats: status of the hypothalamo-pituitary-adrenal axis, and vagal mediation of hyperinsulinaemia. Diabetologia 1997; 40: 1269-1277.
30. Zarjevski N, Cusin I, Vettor R, Rohner-Jeanrenaud F, Jeanrenaud B. Chronic intracerebroventricular neuropeptide-Y administration to normal rats mimics hormonal and metabolic changes of obesity. Endocrinology 1993; 133: 1753-1758.
31. Ionescu E, Rohner-Jeanrenaud F, Berthoud HR, Jeanrenaud B. Increases in plasma insulin levels in response to electrical stimulation of the dorsal motor nucleus of the vagus nerve. Endocrinology 1983; 112: 904-910.
32. Jansen AS, Nguyen XV, Karpitskiy V, Mettenleiter TC, Loewy AD. Central command neurons of the sympathetic nervous system: basis of the fight-or-flight response. Science 1995; 270: 644-646.
33. Jansen ASP, Hoffman JL, Loewy AD. CNS sites involved in sympathetic and parasympathetic control of the pancreas: a viral tracing study. Brain Res 1997; 766: 29-38.
34. Hevener AL, Bergman RN, Donovan CM. Portal vein afferents are critical for the sympathoadrenal response to hypoglycemia. Diabetes 2000; 49: 8-12.
35. Fujita S, Donovan CM. Celiac-superior mesenteric ganglionectomy, but not vagotomy, suppresses the sympathoadrenal response to insulin-induced hypoglycemia. Diabetes 2005; 54: 3258-3264.
36. Fujita S, Bohland M, Sanchez-Watts G, Watts AG, Donovan CM. Hypoglycemic detection at the portal vein is mediated by capsaicin-sensitive primary sensory neurons. Am J Physiol Endocrinol Metab 2007; 293: E96-E101.
37. Frizzell RT, Jones EM, Davis SN et al. Counterregulation during hypoglycemia is directed by widespread brain regions. Diabetes 1993; 42: 1253-1261.
38. Borg WP, Sherwin RS, During MJ, Borg MA, Shulman GI. Local ventromedial hypothalamus glucopenia triggers counterregulatory hormone release. Diabetes 1995; 44: 180-184.
39. Borg MA, Sherwin RS, Borg WP, Tamborlane WV, Shulman GI. Local ventromedial hypothalamus glucose perfusion blocks counterregulation during systemic hypoglycemia in awake rats. J Clin Invest 1997; 99: 361-365.
40. Mccrimmon RJ, Song Z, Cheng H et al. Corticotrophin-releasing factor receptors within the ventromedial hypothalamus regulate hypoglycemia-induced hormonal counterregulation. J Clin Invest 2006; 116: 1723-1730.
41. Cryer PE. Mechanisms of sympathoadrenal failure and hypoglycemia in diabetes. J Clin Invest 2006; 116: 1470-1473.
42. Zhu W, Czyzyk D, Paranjape SA et al. Glucose prevents the fall in ventromedial hypothalamic GABA that is required for full activation of glucose counterregulatory responses during hypoglycemia. Am J Physiol Endocrinol Metab 2010; 298: E971-E977.
43. Fioramonti X, Marsollier N, Song Z et al. Ventromedial hypothalamic nitric oxide production is necessary for hypoglycemia detection and counterregulation. Diabetes 2010; 59: 519-528.
44. Zhou L, Podolsky N, Sang Z et al. The medial amygdalar nucleus: a novel glucose-sensing region that modulates the counterregulatory response to hypoglycemia. Diabetes 2010; 59: 2646-2652.
45. Ritter RC, Slusser PG, Stone S. Glucoreceptors controlling feeding and blood glucose: location in the hindbrain. Science 1981; 213: 451-453.
46. Ritter S, Dinh TT, Zhang Y. Localization of hindbrain glucoreceptive sites controlling food intake and blood glucose. Brain Res 2000; 856: 37-47.
47. Fraley GS, Ritter S. Immunolesion of norepinephrine and epinephrine afferents to medial hypothalamus alters basal and 2-deoxy-d-glucose-induced neuropeptide Y and agouti-gene-related protein messenger ribonucleic acid expression in the arcuate nucleus. Endocrinology 2003; 411: 75-83.
48. Ritter S, Bugarith K, Dinh TT. Immunotoxic destruction of distinct catecholamine subgroups produces selective impairment of glucoregulatory responses and neuronal activation. J Comp Neurol 2001; 43: 197-216.
49. Marty N, Dallaporta M, Thorens B. Brain glucose sensing, counterregulation and feeding behavior. Physiology (Bethesda) 2007; 22: 241-251.
50. Burdakov D, Lesage F. Glucose-induced inhibition: how many ionic mechanisms? Acta Physiol (Oxf) 2010; 198: 295-301.
51. Arluison M, Quignon M, Thorens B, Leloup C, Penicaud L. Immunocytochemical localization of the glucose transporter 2 (GLUT2) in the adult rat brain. II. Electron microscopic study. J Chem Neuroanat 2004; 28: 137-146.
52. Arluison M, Quignon M, Nguyen P, Thorens B, Leloup C, Penicaud L. Distribution and anatomical localization of the glucose transporter 2 (GLUT2) in the adult rat brain-an immunohistochemical study. J Chem Neuroanat 2004; 28: 117-136.
53. Kang L, Routh VH, Kuzhikandathil EV, Gaspers LD, Levin BE. Physiological and molecular characteristics of rat hypothalamic ventromedial nucleus glucosensing neurons. Diabetes 2004; 53: 549-559.
54. Leloup C, Arluison M, Lepetit N et al. Glucose transporter 2 (GLUT2): expression in specific brain nuclei. Brain Res 1994; 638: 221-226.
55. Li B, Xi X, Roane DS, Ryan DH, Martin RJ. Distribution of glucokinase, glucose transporter GLUT2, sulfonylurea receptor-1, glucagon-like peptide-1 receptor and neuropeptide Y messenger RNAs in rat brain by quantitative real time RT-PCR. Brain Res Mol Brain Res 2003; 113: 139-142.
56. Garcia MA, Millan C, Balmaceda-Aguilera C et al. Hypothalamic ependymal-glial cells express the glucose transporter GLUT2, a protein involved in glucose sensing. J Neurochem 2003; 86: 709-724.
57. Maekawa F, Toyoda Y, Torii N et al. Localization of glucokinase-like immunoreactivity in the rat lower brain stem: for possible location of brain glucose-sensing mechanisms. Endocrinology 2000; 141: 375-384.
58. Leloup C, Orosco M, Serradas P, Nicolaidis S, Penicaud L. Specific inhibition of GLUT2 in arcuate nucleus by antisense oligonucleotides suppresses nervous control of insulin secretion. Brain Res Mol Brain Res 1998; 57: 275-280.
59. Wan HZ, Hulsey MG, Martin RJ. Intracerebroventricular administration of antisense oligodeoxynucleotide against GLUT2 glucose transporter mRNA reduces food intake, body weight change and glucoprivic feeding response in rats. J Nutr 1998; 128: 287-291.
60. Thorens B, Guillam M-T, Beermann F, Burcelin R, Jaquet M. Transgenic reexpression of Glut1 or Glut2 in pancreatic b cells rescues Glut2-null mice from early death and restores normal glucose-stimulated insulin secretion. J Biol Chem 2000; 275: 23751-23758.
61. Marty N, Dallaporta M, Foretz M et al. Regulation of glucagon secretion by glucose transporter type 2 (glut2) and astrocyte-dependent glucose sensors. J Clin Invest 2005; 115: 3545-3553.
62. Lynch RM, Tompkins LS, Brooks HL, Dunn-Meynell AA, Levin BE. Localization of glucokinase gene expression in the rat brain. Diabetes 2000; 49: 693-700.
63. Balfour RH, Hansen AM, Trapp S. Neuronal responses to transient hypoglycaemia in the dorsal vagal complex of the rat brainstem. J Physiol 2006; 570: 469-484.
64. Millan C, Martinez F, Cortes-Campos C et al. Glial glucokinase expression in adult and post-natal development of the hypothalamic region. ASN Neuro 2010; 2: e00035.
65. Sanders NM, Dunn-Meynell AA, Levin BE. Third ventricular alloxan reversibly impairs glucose counterregulatory responses. Diabetes 2004; 53: 1230-1236.
66. Levin BE, Becker TC, Eiki J, Zhang BB, Dunn-Meynell AA. Ventromedial hypothalamic glucokinase is an important mediator of the counterregulatory response to insulin-induced hypoglycemia. Diabetes 2008; 57: 1371-1379.
67. Osundiji MA, Hurst P, Moore SP et al. Recurrent hypoglycemia increases hypothalamic glucose phosphorylation activity in rats. Metabolism 2011; 60: 550-556.
68. Dunn-Meynell AA, Routh VH, Kang L, Gaspers L, Levin BE. Glucokinase is the likely mediator of glucosensing in both glucose-excited and glucose-inhibited central neurons. Diabetes 2002; 51: 2056-2065.
69. Wang R, Liu X, Hentges ST et al. The regulation of glucose-excited neurons in the hypothalamic arcuate nucleus by glucose and feeding-relevant peptides. Diabetes 2004; 53: 1959-1965.
70. Yang XJ, Kow LM, Funabashi T, Mobbs CV. Hypothalamic glucose sensor: similarities to and differences from pancreatic beta-cell mechanisms. Diabetes 1999; 48: 1763-1772.
71. Yang XJ, Kow LM, Pfaff DW, Mobbs CV. Metabolic pathways that mediate inhibition of hypothalamic neurons by glucose. Diabetes 2004; 53: 67-73.
72. Dunn-Meynell AA, Rawson NE, Levin BE. Distribution and phenotype of neurons containing the ATP-sensitive K+ channel in rat brain. Brain Res 1998; 814: 41-54.
73. Karschin C, Ecke C, Ashcroft FM, Karschin A. Overlapping distribution of K(ATP) channel-forming Kir6.2 subunit and the sulfonylurea receptor SUR1 in rodent brain. FEBS Lett 1997; 401: 59-64.
74. Inagaki N, Tsuura Y, Namba N et al. Cloning and functional characterization of a novel ATP-sensitive potassium channel ubiquitously expressed in rat tissues, including pancreatic islets, pituitary, skeletal muscle, and heart. J Biol Chem 1995; 270: 5691-5694.
75. Evans ML, Mccrimmon RJ, Flanagan DE et al. Hypothalamic ATP-sensitive K+ channels play a key role in sensing hypoglycemia and triggering counterregulatory epinephrine and glucagon responses. Diabetes 2004; 53: 2542-2551.
76. Miki T, Liss B, Minami K et al. ATP-sensitive K+ channels in the hypothalamus are essential for the maintenance of glucose homeostasis. Nat Neurosci 2001; 4: 507-512.
77. Mccrimmon RJ, Evans ML, Fan X et al. Activation of ATP-sensitive K+ channels in the ventromedial hypothalamus amplifies counterregulatory hormone responses to hypoglycemia in normal and recurrently hypoglycemic rats. Diabetes 2005; 54: 3169-3174.
78. Parton LE, Ye CP, Coppari R et al. Glucose sensing by POMC neurons regulates glucose homeostasis and is impaired in obesity. Nature 2007; 449: 228-232.
79. Minokoshi Y, Alquier T, Furukawa N et al. AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature 2004; 428: 569-574.
80. Hardie DG. Minireview: the AMP-activated protein kinase cascade: the key sensor of cellular energy status. Endocrinology 2003; 144: 5179-5183.
81. Kim MS, Park JY, Namkoong C et al. Anti-obesity effects of alpha-lipoic acid mediated by suppression of hypothalamic AMP-activated protein kinase. Nat Med 2004; 10: 727-733.
82. Han SM, Namkoong C, Jang PG et al. Hypothalamic AMP-activated protein kinase mediates counter-regulatory responses to hypoglycaemia in rats. Diabetologia 2005; 48: 2170-2178.
83. Alquier T, Kawashima J, Tsuji Y, Kahn BB. Role of hypothalamic adenosine 5'-monophosphate-activated protein kinase in the impaired counterregulatory response induced by repetitive neuroglucopenia. Endocrinology 2007; 148: 1367-1375.
84. Mccrimmon RJ, Fan X, Cheng H et al. Activation of AMP-activated protein kinase within the ventromedial hypothalamus amplifies counterregulatory hormone responses in rats with defective counterregulation. Diabetes 2006; 55: 1755-1760.
85. Mccrimmon RJ, Fan X, Ding Y, Zhu W, Jacob RJ, Sherwin RS. Potential role for AMP-activated protein kinase in hypoglycemia sensing in the ventromedial hypothalamus. Diabetes 2004; 53: 1953-1958.
86. Murphy BA, Fakira KA, Song Z, Beuve A, Routh VH. AMP-activated protein kinase and nitric oxide regulate the glucose sensitivity of ventromedial hypothalamic glucose-inhibited neurons. Am J Physiol Cell Physiol 2009; 297: C750-C758.
87. Hayes MR, Skibicka KP, Bence KK, Grill HJ. Dorsal hindbrain 5'-adenosine monophosphate-activated protein kinase as an intracellular mediator of energy balance. Endocrinology 2009; 150: 2175-2182.
88. Mounien L, Marty N, Tarussio D et al. Glut2-dependent glucose-sensing controls thermoregulation by enhancing the leptin sensitivity of NPY and POMC neurons. Faseb J 2010; 24: 1747-1758.
89. Marty N, Dallaporta M, Thorens B. Brain glucose sensing, counterregulation, and energy homeostasis. Physiology (Bethesda) 2007; 22: 241-251.
90. Mobbs CV, Isoda F, Makimura H et al. Impaired glucose signaling as a cause of obesity and the metabolic syndrome: the glucoadipostatic hypothesis. Physiol Behav 2004; 19: 2-23.
91. Thorens B. Glucose sensing and the pathogenesis of obesity and type 2 diabetes. Int J Obes (Lond) 2008; 32(Suppl 6): S62-S71.